NASP Supports Biden Administration’s Rx Drug Cost-cutting Measures for Seniors but Seeks Protections for Pharmacies

April 12, 2022

Sheila Arquette, RPh, CEO and President of the National Association of Specialty Pharmacy (NASP), has praised efforts by the Biden administration and Centers for Medicare and Medicaid Services (CMS) to reduce the high out-of-pocket drug costs seniors face. However, she and the NASP call for CMS to protect patient choice in pharmacies and access to specialty pharmacies.

According to NASP, “Rising pharmacy DIR fees under Medicare Part D have been harming specialty patients who are living with life-altering and life-threatening medical conditions and the pharmacies that serve them. CMS stated in its Medicare Part D proposed rule that pharmacy price concessions (DIR fees) grew a staggering 107,400 percent between 2010 and 2020, with no savings passed onto Medicare beneficiaries. CMS estimates that the reforms outlined in its proposal will lead to over $20 billion in savings for seniors.”

Read more by clicking here.

(Source: NASP, March 8th, 2022)

Share This Story!